PhRMA Foundation: Amy Miller
Amy Miller is the new president at PhRMA Foundation, an organization that invests in healthcare research. Miller takes over the role from Eileen Cannon, who decided to retire after 22 years at the foundation's helm. Previously, Miller was president and CEO of the Society for Women's Health Research and executive VP of the Personalized Medicine Coaltion, where she spearheaded efforts to increase adoption and funding for diagnostics and personalized treatment strategies. According to a statement from PhRMA Foundation, its board of directors unanimously selected Miller as the organization's new president based on her "demonstrated success in nonprofit leadership" and her track record as a "trusted leader and consensus builder among health stakeholders, particularly in precision medicine regulatory issues and in health outcomes and value assessment research."